----
Current ValuationThe current P/E ratio is -19.59, within the reasonable range, cheaper than 55.22% of the time in the past 5 years, and the industry ranks 13/15, the industry Median 17.53.
-19.59xP/E
HK$42.90Stock price
HK$-2.19Earnings per share
-19.59xP/E
Stock priceHK$42.90Earnings per shareHK$-2.19
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- -18.69x
- Typical range
- -30.61x–0.95x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 17.53x
015304560
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 17.53x
0x40x80x120x160x200x
| Name/Symbol | |||
|---|---|---|---|
01548HKGENSCRIPT BIO | -19.59x | 95.09% | HK$97.83B |
02228HKXTALPI | -129.28x | 167.69% | HK$31.40B |
03696HKINSILICO | -13.23x | 100.52% | HK$30.88B |
02576HKTAIMEI TECH | -36.34x | -- | HK$2.73B |
08225HKC HEALTH GP | -4.39x | -- | HK$71.67M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
